Estrogen is a key regulator of the cellular processes involved in the development and maintenance of the reproductive function.
Estrogen is a key regulator of the cellular processes involved in the development and maintenance of the reproductive function. 1) Phytoestrogens are polyphenolic non-steroidal plant compounds with estrogen-like biological activity. Recently, an increasing number of epidemiological and experimental studies has suggested that the consumption of phytoestrogens may have a protective effect on estrogen-related conditions like menopause and estrogen related diseases such as prostate and breast cancers, osteoporosis and cardiovascular diseases. 2) In our search for new phytoestrogens, the ethanolic extract of Cassia tora exhibited a significant stimulation of estrogen dependent MCF-7 cells, suggesting its estrogenic activity. Cassia tora L. (Fabaceae) is widely distributed in tropical Asian countries and its seeds have been used as a traditional medicine for constipation, asthenia, eye disease, hepatitis, diuretic, hemoglobin disorders and as an antidysenteric.
3) Hypotensive activity of the seed extract has also been reported. 4, 5) In India the plant is used for the treatment of snakebites and scorpion stings.
6) The seeds were found to contain a diversity of phenolic constituents, i.e. anthraquinones, naphthopyrones, naphthalenes, hydroanthracenes and their glucosides. [7] [8] [9] [10] [11] These phenolic constituents were reported to have various biological and pharmacological effects such as antibacterial, 11) antifungal, 12) antimutagenic, 13) hypolipidemic 14) and anti-allergic activities. 11) In addition, the aqueous extract of the seed 15) and naphthopyrones 9) and anthraquinones 10) isolated from the seeds exhibited hepatoprotective activity.
In this study, the isolation of two new phenolic triglucosides from a 70% ethanol extract of Cassia tora seeds is reported. Furthermore, a naringinase pretreatment, as a mimic of the metabolic activity of gastro-intestinal flora, was carried out for the ethanolic extract of Cassia tora, and the biologically active principles of this extract were also investigated.
Results
The 70% ethanolic extract of Cassia tora seeds significantly stimulated the proliferation of estrogen dependent MCF-7 cells indicating its possible estrogenic activity, which is significantly increased after being treated with naringinase ( Table 1 ). The 70% ethanolic extract was fractionated on DIAON HP-20 to obtain 3 fractions (25% methanol, 50% methanol, 100% methanol). Estrogenic activity of these fractions was evaluated using MCF-7 cells before and after naringinase treatment (Table 1 ). The 50% methanol fraction and the naringinase pre-treated 70% ethanolic extract were selected for further purification due to their relatively high estrogenic activity. The 50% methanol fraction was subjected to intensive chromatographic purifications using normal and reversed phase silica gel and Sephadex LH-20 to get two new compounds (1, 2) along with seven known compounds [au- 16) torachrysone tetraglucoside (7), rubrofusarin triglucoside (8) 11) and chrysophanol triglucoside (9)]. 9) From the naringinase pretreated total extract six known compounds were isolated and identified as [chrysophanol (10) , physcion (11), 9-methoxychrysophanol (12), 17) aurantio-obtusin (13), 7) toralactone (14) 18) and rubrofusarin (15) ]. (11) In addition, torachrysone (16) 19,20) and 6-hydroxymusizin (17) 16) were obtained through acid hydrolysis of their corresponding isolated glycosides 6 and 7. Finally, nor-rubrofusarin (18) and nor-toralactone (19) were obtained by the demethylation of compounds 14 and 15. The known compounds were identified by comparison with reported data, and the structures of the new compounds were determined as follows.
Estrogenic and Anti-estrogenic Activities of Cassia tora Phenolic Constituents
Compound 1 was obtained as yellow needles. The electron spray ionization mass (ESI-MS) spectrum showed an [MϩH] ϩ ion peak at m/z 733. On the basis of its ESI-MS and elemental analysis data, compound 1 was assigned the molecular formula C 32 H 44 11, 19, 20) Moreover, the presence of three anomeric protons at d In the 13 C-NMR spectrum, the downfield shifted C-6Ј and C-3Љ at d C 68.8 and at d C 88.1, respectively, revealed the presence of 1→6 and 1→3 linkages among the three glucose molecules. 3, 11) In the HMBC spectrum, 1 H-
13
C long-range correlations were observed between the anomeric proton at d H 4.32 (H-1Љ) and the carbon at d C 68.8 (C-6Ј), and between the anomeric proton at d H 4.30 (H-1ٞ) and the carbon at d C 88.1 (C-3Љ), which confirmed the 1→6 and 1→3 linkages. From these findings the structure of compound 1 was determined to be torachrysone (Fig. 1) .
Compound 2 was obtained as yellowish amorphous pow- C-NMR chemical shifts of the sugar moieties, and the comparison of the sugar resulting from the acid hydrolysis of 2 with authentic samples, revealed that the three sugar moieties were D-glucose. 3, 11) The site of attachment of the three glucose units to the aglycone was found to be at OH-9 as indicated from the HMBC correlation between the proton at d H 5.09 (H-1Ј) and the carbon at d C 157.6 (C-9) of the aglycone. Similar to compound 1, the downfield shifted carbons at d C 68.8 and 88.1 corresponding to C-6Ј and C-3Љ, respectively, revealed the presence of 1→6 and 1→3 linkages among the three glucose units. 3) In the HMBC spectrum, long-range correlations were found between the anomeric proton at d H 4.31 (H-1Љ) and the carbon at d C 68.8 (C-6Ј), and between the anomeric proton at d H 4.28 (H-1ٞ) and the carbon at d C 88.1 (C-3Љ) which confirmed the 1→6 and 1→3 linkages. All the glucose moieties were found to be in the b configuration as indicated by the J values of the anomeric protons (Jϭ8 Hz). Based on the formerly mentioned data and by comparison with reported data of rubrofusarin triglucoside and cassiacide C 2 , 3,11) compound 2 was determined to be toralactone
Estrogenic Activity of the Isolated Compounds Using estrogen-dependent MCF-7 cell-proliferation, yeast two hybrid assay expressing ERa and ERb and the ligand binding screen, almost all the isolated compounds from the 50% methanol fraction and the naringinase-pretreated 70% ethanolic extract of Cassia tora were tested for their estrogenic activities at various concentrations. In addition, a group of synthetic compounds (20) (21) (22) (23) (24) , torachrysone (16), 6-hydroxymusizin (17), nor-rubrofusarin (18) and nortoralactone (19) (Fig. 2) were also investigated in order to study the structure activity requirements of these compounds.
Estrogen-Dependent MCF-7 Cells
The positive control 17b-estradiol showed maximum cell proliferation (212.8% of the control) at a concentration of 10 Ϫ12 M (Table 2) . Aurantio- (24) showed significant increase in their estrogenic activity upon decreasing their concentrations with a maximum activity at 10 Ϫ7 M. Nor-rubrofusarin (18) and nor-toralactone (19) significantly stimulated the MCF-7 cell proliferation in a bellshaped manner versus their concentrations, while 1,6-dihydroxynaphthalene (23) showed a significant stimulation of cell proliferation at 10
Yeast Two-Hybrid Assay In the yeast expressing ERa (Table 3) , 6-hydroxymusizin 8-O-b-D-glucoside (6) showed estrogenic activity at 10 Ϫ4 M. In addition, 6-hydroxymusizin (17), nor-rubrofusarin (18) and nor-toralactone (19) showed a significant estrogenic activity at 10 Ϫ4 M. On the other hand, in the yeast expressing ERb, 6-hydroxymusizin 8-O-b-D-glucoside (6) showed estrogenic activity at 10 Ϫ4 M. An appreciable induction of b-galactosidase activity was observed for aurantio-obtusin (12), 6-hydroxymusizin (17) (Table 4) . Anti-estrogenic Activity Using the estrogen-dependent MCF-7 cell proliferation and yeast two-hybrid assays, all the isolated compounds were tested for their anti-estrogenic activities at various concentrations. Inhibition of 17b-estradiol (E 2 )-induced proliferation of MCF-7 cells and E 2 -induced b-galactosidase activity by the isolated compounds were determined under the conditions at which these compounds did not inhibit the proliferation/growth of the MCF-7 and the yeast cells. Tamoxifen, an estrogen receptor antagonist, was used as the positive control. 
Inhibition of 17b b-Estradiol (E 2 )-Induced Stimulation of

MCF-7 Cells
Tamoxifen inhibited the 17b-estradiol-mediated proliferation of MCF-7 cells by 16% at 10 Ϫ5 M (Table 2) . Physcion (11) showed a significant anti-estrogenic activity at 10 Ϫ5 and 10 Ϫ6 M concentrations, while 1,3-dihydroxynaphthalene (22) showed significant anti-estrogenic activity at 10
Inhibition of 17b b-Estradiol-Induced b b-Galactosidase Activity in the Yeast Two-Hybrid Assay In the yeast expressing ERa ( According to the aforementioned data, among the isolated glycosides, aurantio-obtusin 6-O-b-D-glucoside (3) and 6-hydroxymusizin 8-O-b-D-glucoside (6), exhibited weak or no estrogenic activity. Regarding the aglycones and the synthetic compounds, aurantio-obtusin (12), 6-hydroxymusizin (17), nor-rubrofusarin (18), nor-toralactone (19) and 1,3,8-trihydroxynaphthalene (24) exhibited the most potent estrogenic and anti-estrogenic activities in the in vitro assays. On the other hand, toralactone (14) , rubrofusarin (15) and torachrysone (16) showed the most significant anti-estrogenic activity, when evaluated by the yeast two-hybrid assay.
Discussion
Several phenolic compounds such as isoflavonoids, coumestans and lignans were reported to have estrogenic and/or anti-estrogenic activities due to their structural similarity to the mammalian estrogens. The main structural feature of these compounds was reported to be the presence of two phenolic groups separated by a planar core of about 12.8 Å. 21) Despite lacking the formerly mentioned characteristic feature, the naphthopyrones, toralactone (14) and rubrofusarin (15) , and the acetyl naphthalenes, torachrysone (16) and 6-hydroxymusizin (17), exhibited a significant estrogenic and/or anti-estrogenic activities (Tables 4, 5 ). This finding has led us to investigate the main structure requirements responsible for the estrogenic activity of these compounds. Therefore, a group of synthetic compounds (20-24) possessing a partial similarity to the previously mentioned active compounds were investigated for their estrogenic activity. Moreover, demethylation of toralactone (14) and rubrofusarin (15) was carried out to study the effect of the methyl group at position 7 in these compounds on the activity.
Among the tested synthetic and chemically modified compounds, nor-rubrofusrain (18), nor-toralactone (19) and T 3 HN (24) showed almost similar estrogenic and anti-estrogenic activities to those of 6-hydroxymusizin (17) ( Tables  2-5) . By comparing the structures of the formerly mentioned compounds it was found that trihydroxynaphthalene (T 3 HN) is a common feature in these compounds, indicating its principal role in the estrogenic activity. It was also found that methylation of a free hydroxy group at position 3 of the T 3 HN nucleus as in toralactone (14) , rubrofusarin (15) and torachrysone (16) resulted in reduction of estrogenic activity and binding affinity to the estrogenic receptor ERa, but retained anti-estrogenic activity. On the other hand, 1,3-(22) and 1,6-dihydroxylated naphthalene (23) showed weaker estrogenic activities, which confirmed the significance of the trihydroxylated system for effective binding to estrogen receptors.
The estrogenic activity of aurantio-obtusin (13) is in accordance with the previously reported data about the importance of the phenolic group at 2 and 6 position in the antharquinone nucleus for their estrogenic activity. 22) Moreover, physcion (11) , which has a methyl group at the 6 position, showed only anti-estrogenic activity.
To the best of our knowledge, this is the first report about the estrogenic and anti-estrogenic activities of these naturally occurring phenolic compounds based on naphthalene and naphthopyrone nucleuses. Finally, the increase in estrogenic activity of the naringinase pretreated extract of Cassia tora suggests the activation of this extract by intestinal flora.
In conclusion, the current study introduced the 1,3,8-trihydroxynaphthalene (T 3 HN) as a new basic nucleus responsible for estrogenic activity, which might be of interest in the discovery of new estrogenic and anti-estrogenic compounds based on this nucleus.
Experimental
Chemicals and Reagents Naringinase was purchased from Sigma Co. General Experimental Procedures The melting point was measured on a Yanagimoto microhot stage melting point apparatus. Optical rotations were measured with a DIP-360 automatic polarimeter (Jasco Co., Tokyo). Each value represents the meanϮS.E. of three independent experiments (nϭ3). Asterisks denote significant differences from the control at pϽ0.05 ( * ), pϽ0.01 ( * * ). b-Galactosidase activity (U) of 17b-estradiol was 641.2Ϯ22.5 and 2333.4Ϯ112.5 in yeast expressing ERa and ERb, respectively, at a concentration of 10 Ϫ7 M (100%). b-Galactosidase activity (U) of the tested compounds was calculated as a percentage of the 17b-estradiol activity. Compounds 18 and 19 were toxic at a concentration of 10 Ϫ4 M. Tam. denotes (tamoxifen).
UV spectra were measured with a UV-2200 UV-VIS recording spectrophotometer (Shimadzu Co., Kyoto). IR spectra were measured with a Jasco FT/IR-230 infrared spectrometer.
1 H-and 13 C-NMR were measured with a JHA-LAA 400 WB-FT ( 1 H, 400 MHz; 13 C, 100 MHz; Jeol, Tokyo) spectrometer, the chemical shifts being represented as ppm with tetramethylsilane as an internal standard. ESI-MS was carried out on an Esquire 3000 mass spectrometer (Bruker Daltanik GmbH, Bremen, Germany) system with ESI ionization source. Elemental analysis was carried out on a Perkin Elmer analyzer 2400 II. TLC was carried out on precoated silica gel 60 F 254 (0.25 mm, Merck) and RP-18 F 254 S (0.25 mm, Merck Co.). Column chromatography (CC) was carried out on (BW-820MH silica gel), ODS DM 1020T (ODS, Fuji Silysia, Nagoya, Japan), Diaion HP-20 (Mitsubishi Kasei, Tokyo) and Sephadex LH-20 (Pharmacia Co.). Medium pressure liquid chromatography (MPLC) was performed on LiChroprep Rp-18 (size A, Merck Co.). Preparative HPLC was performed on a Tosoh CCPM-CCPM-II system (Tosoh Co., Tokyo) equipped with a UV 8020 detector and TSK gel ODS-80Ts column (21.5ϫ300 mm, Tosoh Co.).
Plant Material Cassia tora seeds were purchased at the Japanese market and identified by a specialist in botanical identification of Suntory Company, Japan (Lot No. T-260).
Extraction and Isolation The seeds of Cassia tora were extracted with 70% ethanol and the extract was concentrated in vacuum. The ethanolic extract (100 g) was suspended in water and fractionated with CHCl 3 (3ϫ1 l) to obtain a chloroform fraction (7 g ). The remaining water solution was applied to a Diaion HP-20 column (60 cmϫ6 cm) and stepwisely eluted with H 2 O, 25% methanol, 50% methanol and 100% methanol. The 50% methanol fraction (60 g) was subjected to a silica gel column eluted with Naringinase Treatment of the Extract and Isolation of the Aglycones 23) The 70% ethanolic extract (25 g) was incubated with naringinase enzyme (12.5 g) in 1000 ml of 0.2 M acetate buffer (pHϭ4.7) at 37°C for 24 h. The solution was extracted with EtOAc three times (500 mlϫ3). The pooled EtOAc extract was evaporated under vacuum to obtain the naringinase treated extract (15 g ). This extract was applied to a silica gel column (30 cmϫ5 cm) eluted with hexane-ethyl acetate (9.5 : 0.5-5 : 5 v/v). Five fractions were obtained and screened for their estrogenic activity using MCF-7 cells. Because of their relatively high estrogenic activity fractions 1 and 2 were selected for further purification. Fraction 1 was applied to silica gel column (15 cmϫ2 cm) using silica gel 60 and gradiently eluted with hexane-ethyl acetate (9.5 : 0.5-9 : 1 v/v) to obtain compounds 10 (300 mg), 11 (25 mg) and 12 (10 mg). The 70% alcoholic extract and 25%, 50% and 100% MeOH fractions of C. tora (40 mg, each) were incubated with naringinase enzyme (20 mg) in 2 ml of 0.2 M acetate buffer (pHϭ4.7) at 37°C for 4 h. The resulting solution was then extracted with BuOH (10 mlϫ3) and the combined BuOH extracts were evaporated under vacuum to get the naringinase-treated extract and fractions. These, in turn, were dissolved in DMSO (10 mg/ml) as stock solutions to test their estrogenic activity.
Acid Hydrolysis of Torachrysone Tetraglucoside (4) and 6-Hydroxymusizin 8-O-b b-D-Glucoside (6)
11)
A solution of 4 and 6 (10 mg of each) in 1% H 2 SO 4 (0.5 ml) in a sealed tube was heated separately on a boiling water bath for 1 h. The solution was then extracted with EtOAC, and concentrated under vacuum to obtain torachrysone (17) (2 mg) and 6-hydroxymusizin (16) (5 mg). Both compounds were identified by 1 
H-NMR and EI-MS.
Acid Hydrolysis of Compounds 1 and 2
11)
A solution of 1 and 2 (4 mg of each) in a 1% H 2 SO 4 (0.2 ml) in a sealed tube was heated on a boiling water bath for 1 h. The solution was then extracted with EtOAc, and concentrated under vacuum to get torachrysone and toralactone, respectively, and the identity of the aglycones was verified by 1 H-NMR, EI-MS, TLC and by comparison with the reported data. 11, 13, [18] [19] [20] The aqueous layer was neutralized with sodium carbonate and freeze dried. The sugar component of the residue was detected by TLC through comparison with authentic samples to be glucose. The absolute configuration of the sugar was determined as D-glucose according to the method described by Hara et al. 25) Demethylation of Toralactone (14) and Rubrofusrin (15)
24)
Toralactone and rubrofusarin (5 mg each) were separately dissolved in acetic anhydride (5 ml), treated gradually with HI (dϭ1.7) and refluxed gently for 2 h with occasional shaking. At the end of the reaction, a saturated solution of sodium thiosulfate (5 ml) was added. The resulting mixture was extracted by EtOAc and evaporated under vacuum. The resulting demethylated compounds were purified using prep HPLC (acetonitrile: 0.1% TFA/H 2 O (80% v/v), 5 ml/min, monitored at 285 nm) to afford nor rubrofusrin (18) (2 mg) and nor toralactone (19) (1.5 mg) .
MCF-7 Cells Proliferation Assay Estrogen-sensitive human MCF-7 breast cells were grown in DMEM supplemented with 5% FBS, penicillin, and streptomycin. The cells were harvested by trypsinization (0.25% trypsin) and plated at a concentration of 5ϫ10 3 cells/well in DMEM supplemented with 5% FBS in 96-well tissue culture plates (Iwaki Co., Chiba, Japan) and allowed to attach for 24 h. Then the culture medium was replaced with phenol red-free DMEM containing 10% heat-inactivated dextran/charcoalstripped (DC) human serum prior to the addition of compounds and 17b-estradiol. Stock solutions of test compounds in DMSO were diluted with DC medium. The final DMSO concentration in culture medium did not exceed 0.1%, and this concentration did not affect cell viability. After 4 d in a humidified incubator with 5% CO 2 at 37°C, the proliferation of the cells was measured using the MTT method.
26)
Yeast Two-Hybrid Assay The yeast two-hybrid assay was carried out according to the method of Nishikawa and Kanayama. 27, 28) Briefly, yeast cells expressing ERa and ERb were separately grown overnight at 30°C with shaking in a synthetic defined medium (SD) lacking tryptophan and leucine. Yeast cells were treated with 17b-estradiol and the isolated compounds for 4 h at 30°C, and b-galactosidase activity was determined as fol-lows. The growth of the yeast cells was monitored by measuring the turbidity at 600 nm. The treated yeast cells were collected by centrifugation (8000ϫg, 5 min) and re-suspended in 200 ml of Z-buffer (0.1 M sodium phosphate, pH 7.0, 10 mM KCl, and 1 mM MgSO 4 ) containing 1 mg/ml of zymolyase at 37°C for 15 min. The reaction was started by the addition of 40 ml of 4 mg/ml O-nitrophenol b-D-galactopyranoside (ONPG) as a substrate. When a yellow color developed (incubation time: t), 100 ml of 1 M Na 2 CO 3 was added to stop the reaction. The absorbance of the solution (150 ml) was measured at 420 and 550 nm. The b-galactosidase activity was determined using the following formula:
Uϭ1000ϫ(A 420 Ϫ1.75ϫA 550 )/(tϫ0.05ϫA 600 )
Ligand Binding Screen An estrogen-R (a) competitor screening kit was purchased from Wako Chemicals Japan Inc. The assay depends on the competition between the samples applied in different concentrations and the labeled estrogen mixture. The amount of the ligand that binds to the ERa coated on the microplate well is determined by the dynamic equilibrium among all the ligand concentrations in the mixture, the difference of their binding affinities to the receptor and the incubation time. Therefore, the reduction in fluorescence intensities from the labeled estrogen retained is an indication of the affinity of the added compounds to the estrogen receptor. The isolated compounds were tested in 10 Ϫ5 , 10 Ϫ4 and 5ϫ10 Ϫ3 M concentrations. Estradiol was used as a positive control and a labeled estrogen mixture was used as a negative control. The results were calculated as percentages of the negative control.
Anti-estrogenic Assay To examine the antagonistic activity of the test compounds, the inhibition of b-galactosidase activity and the proliferation of MCF-7 cells, which had been induced by 10 Ϫ7 M and 10 Ϫ12 M 17b-estradiol, respectively, were measured at various concentrations of test compounds.
Statistical Analysis Each set of experiments was repeated at least three times. Values are expressed as meanϮS.E.M. One-way analysis of variance followed by Dunnett's test was used for statistical analysis.
